Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Chiaki Hidai"'
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract The purpose of this study was to clarify the relationship among X-box-binding protein 1 unspliced, spliced (XBP1u, s), Forkhead box O1 (FoxO1) and autophagy in the auditory cells under endoplasmic reticulum (ER) stress. In addition, the rela
Externí odkaz:
https://doaj.org/article/ce771875e796400bbd76d30f7052ea99
Autor:
Chiaki Hidai, Hisataka Kitano
Publikováno v:
Diseases, Vol 6, Iss 3, p 57 (2018)
Although the development of effective viral vectors put gene therapy on the road to commercialization, nonviral vectors show promise for practical use because of their relative safety and lower cost. A significant barrier to the use of nonviral vecto
Externí odkaz:
https://doaj.org/article/c7219ef97c7f4e9a8d10937ab47478c4
Publikováno v:
Journal of Nihon University Medical Association. 81:355-365
Autor:
HISATAKA KITANO, TOMOMI ISHIKAWA, YOH MASAOKA, KAZUHIRO KOMIYAMA, MAMIKO TAKAHASHI, CHIAKI HIDAI
Publikováno v:
In Vivo; Jul/Aug2023, Vol. 37 Issue 4, p1486-1497, 12p
Publikováno v:
Biologicals
Background The successful development of messenger RNA vaccines for SARS-CoV-2 opened up venues for clinical nucleotide-based vaccinations. For development of DNA vaccines, we tested whether the EGF domain peptide of Developmentally regulated endothe
Publikováno v:
Biochemical and biophysical research communications. 569
Recently, coagulation factor IX and its activation peptide have been reported to suppress the permeability of vascular endothelial cells. In this study, the therapeutic effects of a synthesized activation peptide is investigated in traumatic brain in
Autor:
Chiaki Hidai
Publikováno v:
Journal of Nihon University Medical Association. 79:167-169
Autor:
Chiaki Hidai, Tomomi Ishikawa, Yoh Masaoka, Atsushi Mamiya, Hisataka Kitano, Yusuke Fujiwara, Toshio Miki
Publikováno v:
Revista de investigaci�n Cl�nica. 73
espanolAntecedentes: Se espera que la terapia genica del cancer que utiliza un vector no viral sea repetible, segura y economica, y que tenga una eficacia a largo plazo. Se ha demostrado que la terapia genica que utiliza el dominio E3 y C1 (E3C1) del
Publikováno v:
Translational Cancer Research. 7:686-694
Publikováno v:
Cell Biology International. 41:374-383
Lipid rafts are an initiation site for many different signals. Recently, we reported that an EGF domain in activated coagulation factor IX (EGF-F9) increases lipid raft formation and accelerates cell migration. However, the detailed mechanism is not